Definitive Contract 00261200209D261025113
Ended Awarded Last action
- Contract number
- 00261200209D261025113
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $349,000
Award facts
- Contract value 50% obligated
- $698,236.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers
- Pricing
- Firm Fixed Price
- Place of performance
- Illinois, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $349,000 |
About this award
This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation.
IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of Health (NIH). Under this contract, IITRI will likely conduct preclinical drug testing and research support services, such as pharmacology, toxicology, safety and efficacy evaluations of small molecules, biologics, and RNA therapeutics across disease areas.
The contract appears to be associated with larger IDIQ (Indefinite Delivery/Indefinite Quantity) contract vehicles that IITRI holds with various NIH institutes, including the National Cancer Institute (NCI), National Institute of Neurological Disorders and Stroke (NINDS), National Center for Advancing Translational Sciences (NCATS), and National Institute of Allergy and Infectious Diseases (NIAID). These IDIQ contracts have a combined potential value in the hundreds of millions of dollars to provide preclinical drug development services to federal agencies on an as-needed basis.
Quick answers
Who was awarded contract 00261200209D261025113?
00261200209D261025113 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 15, 2002.
How much is contract 00261200209D261025113 worth?
The government has obligated $349,000 on 00261200209D261025113. Its current value, with exercised options, is $698,236.
Was contract 00261200209D261025113 competed?
The extent of competition for 00261200209D261025113 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award